234 related articles for article (PubMed ID: 18568357)
1. Migration of levonorgestrel IUS in a patient with complex medical problems: what should be done?
Soleymani Majd H; El Hamamy E; Chandrasekar R; Ismail L
Arch Gynecol Obstet; 2009 Mar; 279(3):385-6. PubMed ID: 18568357
[TBL] [Abstract][Full Text] [Related]
2. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
3. [Abdominal migration of a levonorgestrel-releasing intrauterine device. Case report and review of the literature].
Pont M; Lantheaume S
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):179-81. PubMed ID: 19303222
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
Li CF; Lee SS; Pun TC
Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
[TBL] [Abstract][Full Text] [Related]
5. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
Rose S; Chaudhari A; Peterson CM
Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
[TBL] [Abstract][Full Text] [Related]
6. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
7. Intravesical migration of levonorgestrel-releasing intrauterine system (LNG-IUS) with calculus formation.
Khan ZA; Khan SA; Williams A; Mobb GE
Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):243-5. PubMed ID: 17056458
[TBL] [Abstract][Full Text] [Related]
8. The levonorgestrel intrauterine system in nulliparous women.
Prager S; Darney PD
Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy in a patient with a displaced levonorgestrel-releasing intrauterine system: a case report.
Budiman H; Kümper C; Mylonas I; Thaler CJ; Friese K; Weissenbacher ER
Arch Gynecol Obstet; 2007 Sep; 276(3):263-4. PubMed ID: 17356827
[TBL] [Abstract][Full Text] [Related]
10. [Is gestagen IUD a realistic alternative to female sterilization?].
Bjerge MR; Helm P
Ugeskr Laeger; 2005 Jun; 167(25-31):2770-2. PubMed ID: 16014263
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
Daud S; Ewies AA
Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
[TBL] [Abstract][Full Text] [Related]
12. Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.
Donders GG; Berger J; Heuninckx H; Bellen G; Cornelis A
Contraception; 2011 Apr; 83(4):352-6. PubMed ID: 21397094
[TBL] [Abstract][Full Text] [Related]
13. Algorithm for nonvisible strings of levonorgestrel intrauterine system.
Vilos GA; Di Cecco R; Marks J
J Minim Invasive Gynecol; 2010; 17(6):805-6. PubMed ID: 20955995
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine contraception--what now and what next?
Guillebaud J
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():11-4. PubMed ID: 11336428
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing intrauterine device and uterine perforations.
Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
Neven P; Amant F; Poppe W; Van den Broecke R
Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
[No Abstract] [Full Text] [Related]
18. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
19. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy.
Kadir RA; Chi C
Contraception; 2007 Jun; 75(6 Suppl):S123-9. PubMed ID: 17531603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
